Karamtara Engineering IPO
₹241 – ₹241 · Issue Size ₹875 CrIPO Overview
Business Model
Our Promoters and Promoter Group", "Restated Consolidated
IPO Timeline
Risk Factors
(formerly known as IIFL Securities Limited) Dhruv Bhavsar /
Management & Promoters
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Karamtara Engineering IPO | — | — |
| Dated January | 22.0x | — |
| Please read Section of the Companies Act | 32.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| March 2024 | ₹473.48 Cr | ₹589.91 Cr | — | ₹21,914.41 Cr |
| March 2023 | ₹139.93 Cr | ₹389.21 Cr | — | ₹16,821.29 Cr |
| March 2022 | ₹248.94 Cr | ₹1,026.5 Cr | — | ₹18,445.62 Cr |
| September 2024 | ₹140.82 Cr | ₹423.6 Cr | — | ₹15,369 Cr |
| September 2023 | ₹113.51 Cr | ₹126.46 Cr | — | ₹15,440.5 Cr |
About
Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica
Key Regulations and Policies", "History and Certain Corporate Matters", "Restated Consolidated Financial Information", "Financial Indebtedness", "Outstanding Litigation and Material Developments", "Other Regulatory and Statutory Disclosures" and "Main Provisions of Articles of Association" beginning on pages 96, 111, 123, 128, 227, 234, 272, 336,365, 375 and 419, respectively, shall have the meanings ascribed to them in the relevant section. Conventional and General Terms Term Description "our Company"/ "the Company", "the Issuer" Karamtara Engineering Limited, a public limited company inc
| Exchange | NSE |
| Issue Type | mainboard |
| Face Value | ₹10 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.